Association between gp120 envelope V1V2 and V4V5 variable loop profiles in a defined HIV-1 transmission cluster

被引:9
|
作者
Pollakis, Georgios [1 ,2 ]
Baan, Elly [2 ]
van Werkhoven, Maaike B. [2 ]
Berkhout, Ben [2 ]
Bakker, Margreet [2 ]
Jurriaans, Suzanne [3 ]
Paxton, William A. [1 ,2 ]
机构
[1] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool L69 3BX, Merseyside, England
[2] Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, Amsterdam, Netherlands
关键词
HIV type 1; transmission cluster; V1V2 and V4V5 variable loops; IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; TO-CHILD TRANSMISSION; CORECEPTOR USAGE; DC-SIGN; GENOTYPIC CHARACTERISTICS; ANTIBODY NEUTRALIZATION; SELECTIVE TRANSMISSION; DENDRITIC CELLS; GLYCOPROTEIN;
D O I
10.1097/QAD.0000000000000692
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective:Variations in the HIV-1 gp120 Env variable loop sequences correlate with virus phenotypes associated with transmission and/or disease progression. We aimed to identify whether signature sequences could be identified in the gp120 Env between acute infection and chronic infection viruses obtained from a group of individuals infected with closely related viruses.Methods:To analyse acute infection versus chronic infection viruses, we studied a transmission cluster of 11 individuals, in which six presented during acute infection and five during chronic infection. Multiple HIV-1 gp120 Env clones were sequenced from each patient with predicted amino acid sequences compared between the groups.Results:Cluster analysis of V1V5 Env sequences (n=215) identified that acute infection viruses had lower potential N-linked glycosylation site (PNGS) densities than viruses from chronic infection, with a higher amino acid length/PNGS ratio. We found a negative correlation between the V1V2 and V4V5 regions for both amino acid length (Pearson P<0.01) and PNGS numbers (Pearson P<0.01) during HIV-1 transmission. This association was lost following seroconversion. These findings were confirmed by analysing sequences from the Los Alamos database that were selected and grouped according to timing of transmission. This included acute infection sequences collected 0-10 days (n=400) and chronic infection sequences 0.5-3 years postseroconversion (n=394).Conclusion:Our observations are consistent with a structural association between the V1V2 and V4V5 gp120 regions that is lost following viral transmission. These structural considerations should be taken into consideration when devising HIV-1 immunogens aimed at inducing protective antibody responses targeting transmitted viruses.
引用
收藏
页码:1161 / 1171
页数:11
相关论文
共 50 条
  • [21] Two Conserved Tyrosines in the HIV-1 Envelope V2 Loop Play a Critical Role in gp120/gp41 Association
    Guzzo, Christina
    Zhang, Peng
    Lusso, Paolo
    Liu, Qingbo
    Cimbro, Raffaello
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 93 - 93
  • [22] The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry
    Cardaci, Sabrina
    Soster, Marco
    Bussolino, Federico
    Marchio, Serena
    FEBS LETTERS, 2013, 587 (18) : 2943 - 2951
  • [23] HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
    Xiaoying Shen
    Fatima Laher
    Zoe Moodie
    Arthur S. McMillan
    Rachel L. Spreng
    Peter B. Gilbert
    Ying Huang
    Nicole L. Yates
    Nicole Grunenberg
    M. Juliana McElrath
    Mary Allen
    Michael Pensiero
    Vijay L. Mehra
    Olivier Van Der Meeren
    Susan W. Barnett
    Sanjay Phogat
    Glenda E. Gray
    Linda-Gail Bekker
    Lawrence Corey
    Georgia D. Tomaras
    Scientific Reports, 10
  • [24] Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop
    Tamamis, Phanourios
    Floudas, Christodoulos A.
    PLOS ONE, 2014, 9 (04):
  • [25] HIV-1 V1V2 envelope sequences influence neurotropism and differ between demented and nondemented patients
    Power, C
    McArthur, JC
    Glass, JD
    Langelier, T
    Wehrly, K
    Chesebro, B
    NEUROLOGY, 1997, 48 (03) : 2006 - 2006
  • [26] Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer
    Liu, Li
    Cimbro, Raffaello
    Lusso, Paolo
    Berger, Edward A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (50) : 20148 - 20153
  • [27] HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
    Shen, Xiaoying
    Laher, Fatima
    Moodie, Zoe
    McMillan, Arthur S.
    Spreng, Rachel L.
    Gilbert, Peter B.
    Huang, Ying
    Yates, Nicole L.
    Grunenberg, Nicole
    McElrath, M. Juliana
    Allen, Mary
    Pensiero, Michael
    Mehra, Vijay L.
    Van Der Meeren, Olivier
    Barnett, Susan W.
    Phogat, Sanjay
    Gray, Glenda E.
    Bekker, Linda-Gail
    Corey, Lawrence
    Tomaras, Georgia D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
    Shen, Xiaoying
    Korber, Bette
    Spreng, Rachel L.
    Sawant, Sheetal S.
    Decamp, Allan
    Mcmillan, Arthur S.
    Mathura, Ryan
    Zolla-Pazner, Susan
    Pinter, Abraham
    Parks, Robert
    Bowman, Cindy
    Sutherland, Laura
    Scearce, Richard
    Yates, Nicole L.
    Montefiori, David C.
    Haynes, Barton F.
    Tomaras, Georgia D.
    VACCINES, 2025, 13 (02)
  • [29] Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits
    Jiang, Xunqing
    Totrov, Max
    Li, Wei
    Sampson, Jared M.
    Williams, Constance
    Lu, Hong
    Wu, Xueling
    Lu, Shan
    Wang, Shixia
    Zolla-Pazner, Susan
    Kong, Xiang-Peng
    JOURNAL OF VIROLOGY, 2016, 90 (24) : 11007 - 11019
  • [30] Antibodies Targeting the V1V2 Domain of gp120 Display Strong ADCC and Inhibitory Activities
    Mayr, Luzia
    Decoville, Thomas
    Schmidt, Sylvie
    Laumond, Geraldine
    Ducloy, Camille
    Klingler, Jeromine
    Salome, Nathalie
    Zolla-Pazner, Susan
    Moog, Christiane
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 111 - 111